Faiza Beauty Cream Recalled for Marketing Without FDA Approval
New Reliance Trading, Inc. is recalling No.1 Faiza Beauty Cream because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is reasonably likely to cause temporary or medically reversible adverse health consequences. The source text does not report any specific illnesses or injuries, and the hazard is the lack of regulatory approval rather than a confirmed contamination or defect.
Plain-English summary
New Reliance Trading, Inc. is recalling No.1 Faiza Beauty Cream, manufactured by Poonia Brothers (Pak) in Gujranwala, Pakistan. The product is distributed in New York and is identified by UPC codes 8993138993349 and 5842109854239. The recall involves 513 foil packets.
The recall is being conducted because the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). This means the product has not been evaluated by the FDA for safety, efficacy, or quality.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund or contact the distributor for further instructions.
The recalled product
- Product
- No.1 Faiza Beauty Cream Manufactured by: Poonia Brothers (Pak), Gujranwala, Distributed by NEW RELIANCE TRADING, INC., 5563 59th St., Maspeth, New York, 11378-2358, UPC 8993138993349, 5842109854239.
- Manufacturer
- NEW RELIANCE TRADING, INC.
- Category
- Drug — Cosmetic/Drug Combination
- Hazard
- Affected units
- 513
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UPC 8993138993349
- 5842109854239
Distribution
Distributed in 1 state:
Related recalls
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
Similar recalls
- ModerateFDA Recalls Unapproved Faiza Beauty Cream Distributed in New York
FDA (Drugs) · 2017-11-29
- SevereFlawless Beauty Recalls Reiki Glutathione Whitening Kits for Misbranding
FDA (Drugs) · 2018-02-14
- HighFlawless Beauty Recalls Relumins Advanced Glutathione Kits Nationwide
FDA (Drugs) · 2018-02-14
- SevereFDA Recalls Unapproved Zhong Hua Niu Bian Capsules Nationwide
FDA (Drugs) · 2016-06-01
- SevereFlawless Beauty LLC Recalls Ling Zhi Capsules for Misbranding
FDA (Drugs) · 2018-02-14
- SevereFlawless Beauty Recalls Unapproved Saluta Glutathione Whitening Kits Nationwide
FDA (Drugs) · 2018-02-14